About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Over-Prescription Of Drugs - Cause Of Concern For UK Government Health Officials

by Rishika Gupta on December 9, 2018 at 11:00 AM
Font : A-A+

Over-Prescription Of Drugs - Cause Of Concern For UK Government Health Officials

The British Health Secretary Matt Hancock has called a review to end "polypharmacy." As during a survey it was found that nearly half of those over 75-year-olds were taking five or more medicines.

The review will look at patients most at risk of suffering from adverse effects from overprescribing of tablets and pills, Xinhua news agency reported.

Advertisement


Spending on medicines by the National Health Service (NHS) in England has grown from $16.55 billion in 2010-2011 to over $23 billion in 2017-2018, an average growth of around 5 percent .

It now means 1.1 billion prescriptions for medicines are dispensed every year by family doctors, known as GPs.

Chief Pharmaceutical Officer Dr. Keith Ridge will lead the review into medicine use. He will look at addressing "problematic polypharmacy" where patients take multiple medicines unnecessarily, the report said.
Advertisement

Ridge said recent successes by NHS England to reduce unnecessary antibiotics and medicines in care homes and family doctor surgeries, known as polypharmacy, are beginning to end overmedication for people with learning disabilities, showing what can be done on what is an important topic.

The review will consider individual circumstances where patients may be most at risk of suffering from adverse effects from overprescribing.

The overprescribing of medicines can be dangerous for older people who often take a cocktail of different medicines to manage complex health conditions, said health officials.

They may suffer side effects of their medicine regimes that lead to them falling and being admitted to hospital. Some patients remain for years on repeat prescriptions which roll over without ever being reviewed by doctors.

The British Health Secretary said: "Poorly managed prescribing can lead to serious issues for patients such as increased admissions to hospital or antibiotic resistance.

"As we invest an extra 20.5 billion pounds ($26.1 billion) a year into our NHS we want to empower doctors and pharmacists to use the data available to ensure patients get the medicines they need and stop taking those that no longer benefit them."

The survey will also look at the role of digital technologies in reducing overprescribing as well as increasing other forms of care, including social prescribing.

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Ways to Manage Stress during COVID-19 Pandemic
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Drugs Banned in India Health Insurance - India 

Recommended Reading
Over-Prescription of Opioids After Rhinoplasty
Opioids are commonly prescribed after rhinoplasty. Characterizing opioid use after rhinoplasty ......
Over-prescription of Acid-suppressing Drugs in Infants
Physicians frequently prescribe acid-suppressing drugs to infants with gastroesophageal reflux ......
Study Finds Over-prescription of Statins For Healthy People
Cholesterol-lowering statin medications, miracle drugs for those suffering from heart disease, may ....
Rising Use of Opioid Pain Medication Following Low-Risk Surgeries
Physicians are prescribing more opioid painkillers than ever before to patients undergoing common .....
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Health Insurance - India
Health insurance has emerged as one of the fastest growing segments in the non-life insurance indust...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use